DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Dungan KM, Povedano ST, Forst T et al.
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label phase 3, non-inferiority trial.
Lancet 2014;
384: 1349-1357
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.